Bone morphogenetic proteins in cranial reconstructions: clinical evaluation of heparin-chitosan as a carrier for BMP-2.
Docherty Skogh
Ann-Charlott
AC
Craniofacial Center; Department of Reconstructive Plastic Surgery; Karolinska University Hospital and Karolinska Institute; Stockholm, Sweden.
Engstrand
Thomas
T
D001672:Biocompatible Materials; D055396:Bone Morphogenetic Protein 2 / Q000378:metabolism*; D048271:Chitosan / Q000494:pharmacology*; D005343:Fibrinolytic Agents / Q000494:pharmacology*; D005624:Frontal Bone / Q000378:metabolism* / Q000601:surgery*; D006493:Heparin / Q000494:pharmacology*; D006801:Humans; D019651:Plastic Surgery Procedures / Q000379:methods*; D013526:Surgical Mesh; D013701:Temporal Bone / Q000378:metabolism* / Q000601:surgery*
C525718:BMP2 protein, human; D001672:Biocompatible Materials; D055396:Bone Morphogenetic Protein 2; D005343:Fibrinolytic Agents; D006493:Heparin; D048271:Chitosan